Baidu
map

J Cosmet Dermatol:愈疮木和桃金娘提取物在治疗敏感性皮肤上的寻常痤疮中展现出协同作用

2024-05-28 MedSci原创 MedSci原创 发表于上海

愈疮木和桃金娘提取物在协同抑制炎症、改善寻常痤疮和减轻发红方面具有显著疗效。

寻常痤疮是全球常见的慢性皮肤病,主要发生在面部、颈部、手臂、上胸部和背部,会导致瘢痕和炎症后色素沉着。面部痤疮不仅影响外观,还会出现瘙痒、红斑和疼痛等症状,影响整体健康和生活质量。寻常痤疮的发病机制错综复杂,其中,炎症和痤疮丙酸杆菌在痤疮的发病中起着关键作用。最近的研究表明,敏感性皮肤的痤疮发病率很高。 对于寻常痤疮患者来说,痤疮的频繁爆发可能会损害皮肤屏障,从而降低免疫防御能力,增加敏感性。这可能会导致炎症持续存在或痤疮反复发作,形成寻常痤疮和敏感性皮肤的恶性循环。治疗痤疮的传统强效药物,如羟基酸(水杨酸、果酸和杜鹃花酸)、异维A酸、过氧化苯甲酰、化学去角质剂和激光治疗等,可能会引起皮肤刺激和副作用,给痤疮患者和敏感性皮肤患者带来挑战。因此对患有寻常型痤疮且皮肤敏感的患者来说,适合的治疗方法非常有限。

J Cosmet Dermatol最新的一篇研究报告,研究者评估了愈疮木(GO)和桃金娘RT)提取物通过抑制炎症治疗敏感性皮肤上的寻常型痤疮的协同作用。

研究在体外测定GORT提取物的植物化学成分和抗氧化活性。在肽聚糖(PGN)诱导的 HaCaT 细胞中研究了其抗炎效果。此外,还对 30 名敏感性皮肤和痤疮患者进行了为期 28 天的临床试验,以评估其疗效和受试者的满意度。

结果表明,在GORT提取物中检测到了总酚和类黄酮,其清除DPPH自由基的IC50值分别为6.15 wt%0.76 wt%。与单独使用 GO 提取物相比,GO RT 提取物以 1:1 (v/v) 的比例混合使用可显著降低 PGN 诱导的 HaCaT 细胞中 TLR-2 TLR-4 的表达,以及 IL-1αIL-8 TNF-α 的分泌,降低幅度为 2.30-7.93 倍(p < 0.05)。此外,含有 5 wt%组合物的面霜能明显改善面部痤疮和发红现象(p < 0.05)。使用 28 天后,粉刺数量减少了 50.00%,丘疹减少了 30.65%。无不良反应报告,96.67%的受试者对治疗效果表示满意。

综上,GO RT 提取物在协同抑制炎症、改善寻常痤疮和减轻发红方面具有显著疗效。这项研究为敏感性皮肤的寻常型痤疮患者提供了一种有效且无刺激的治疗方法。

原始出处:

Zhang J, Liu S, Guo W, Li N. The synergistic effects of Guaiacum officinale and Rhodomyrtus tomentosa extracts in the treatment of acne vulgaris on sensitive skin. J Cosmet Dermatol. 2024 May 24. doi: 10.1111/jocd.16394. Epub ahead of print. PMID: 38790116. 

相关资料下载:
[AttachmentFileName(sort=100, fileName=J Cosmet Dermatol:愈疮木和桃金娘提取物在治疗敏感性皮肤上的寻常痤疮中展现出协同作用)] GetArticleByIdResponse(id=5d6182e881a7, projectId=1, sourceId=null, title=J Cosmet Dermatol:愈疮木和桃金娘提取物在治疗敏感性皮肤上的寻常痤疮中展现出协同作用, articleFrom=MedSci原创, journalId=11903, copyright=原创, creationTypeList=[1], summary=愈疮木和桃金娘提取物在协同抑制炎症、改善寻常痤疮和减轻发红方面具有显著疗效。, cover=https://img.medsci.cn/20240528/1716894114926_8439950.png, authorId=0, author=, originalUrl=, linkOutUrl=, content=<p><span style="color: #212121;">寻常痤疮是全球常见的慢性<a href="//www.sandwebs.com/topic/show?id=f6a6e206066">皮肤病</a>,主要发生在面部、颈部、手臂、上胸部和背部,会导致瘢痕和炎症后色素沉着。面部痤疮不仅影响外观,还会出现瘙痒、红斑和疼痛等症状,影响整体健康和<a href="//m.sandwebs.com/scale/show.do?id=4c862426ef">生活质量</a>。寻常痤疮的发病机制错综复杂,其中,炎症和痤疮丙酸杆菌在痤疮的发病中起着关键作用。最近的研究表明,敏感性皮肤的痤疮发病率很高。</span> <span style="color: #212121;">对于寻常痤疮患者来说,痤疮的频繁爆发可能会损害皮肤屏障,从而降低<a href="//www.sandwebs.com/guideline/search?keyword=%E5%85%8D%E7%96%AB">免疫</a>防御能力,增加敏感性。这可能会导致炎症持续存在或痤疮反复发作,形成寻常痤疮和敏感性皮肤的恶性循环。治疗痤疮的传统强效药物,如羟基酸(水杨酸、果酸和杜鹃花酸)、异维</span><span style="color: #212121;">A</span><span style="color: #212121;">酸、过氧化苯甲酰、化学去角质剂和激光治疗等,可能会引起皮肤刺激和副作用,给痤疮患者和敏感性皮肤患者带来挑战。因此对患有寻常型痤疮且皮肤敏感的患者来说,适合的治疗方法非常有限。</span></p> <p><span style="color: #212121;">J Cosmet Dermatol</span><span style="color: #3b3030;">最新的一篇研究报告,</span>研究者<span style="color: #212121;">评估了愈疮木(</span><span style="color: #212121;">GO</span><span style="color: #212121;">)和</span><span style="color: #333333;">桃金娘</span><span style="color: #212121;">(</span><span style="color: #212121;">RT</span><span style="color: #212121;">)提取物通过抑制炎症治疗敏感性皮肤上的寻常型痤疮的协同作用。</span></p> <p><span style="color: #212121;"> <img class="wscnph" src="https://img.medsci.cn/20240528/1716893961989_8439950.jpg" /></span></p> <p><span style="color: #212121;">研究在体外测定</span><span style="color: #212121;">GO</span><span style="color: #212121;">和</span><span style="color: #212121;">RT</span><span style="color: #212121;">提取物的植物化学成分和抗氧化活性。在肽聚糖(</span><span style="color: #212121;">PGN</span><span style="color: #212121;">)诱导的</span><span style="color: #212121;"> HaCaT </span><span style="color: #212121;">细胞中研究了其抗炎效果。此外,还对</span><span style="color: #212121;"> 30 </span><span style="color: #212121;">名敏感性皮肤和痤疮患者进行了为期</span><span style="color: #212121;"> 28 </span><span style="color: #212121;">天的临床试验,以评估其疗效和受试者的满意度。</span></p> <p><span style="color: #212121;">结果表明,在</span><span style="color: #212121;">GO</span><span style="color: #212121;">和</span><span style="color: #212121;">RT</span><span style="color: #212121;">提取物中检测到了总酚和类黄酮,其清除</span><span style="color: #212121;">DPPH</span><span style="color: #212121;">自由基的</span><span style="color: #212121;">IC50</span><span style="color: #212121;">值分别为</span><span style="color: #212121;">6.15 wt%</span><span style="color: #212121;">和</span><span style="color: #212121;">0.76 wt%</span><span style="color: #212121;">。与单独使用</span><span style="color: #212121;"> GO </span><span style="color: #212121;">提取物相比,</span><span style="color: #212121;">GO </span><span style="color: #212121;">和</span><span style="color: #212121;"> RT </span><span style="color: #212121;">提取物以</span><span style="color: #212121;"> 1:1 (v/v) </span><span style="color: #212121;">的比例混合使用可显著降低</span><span style="color: #212121;"> PGN </span><span style="color: #212121;">诱导的</span><span style="color: #212121;"> HaCaT </span><span style="color: #212121;">细胞中</span><span style="color: #212121;"> TLR-2 </span><span style="color: #212121;">和</span><span style="color: #212121;"> TLR-4 </span><span style="color: #212121;">的表达,以及</span><span style="color: #212121;"> IL-1&alpha;</span><span style="color: #212121;">、</span><span style="color: #212121;">IL-8 </span><span style="color: #212121;">和</span><span style="color: #212121;"> TNF-&alpha; </span><span style="color: #212121;">的分泌,降低幅度为</span><span style="color: #212121;"> 2.30-7.93 </span><span style="color: #212121;">倍(</span><span style="color: #212121;">p &lt; 0.05</span><span style="color: #212121;">)。此外,含有</span><span style="color: #212121;"> 5 wt%</span><span style="color: #212121;">组合物的面霜能明显改善面部痤疮和发红现象(</span><span style="color: #212121;">p &lt; 0.05</span><span style="color: #212121;">)。使用</span><span style="color: #212121;"> 28 </span><span style="color: #212121;">天后,粉刺数量减少了</span><span style="color: #212121;"> 50.00%</span><span style="color: #212121;">,丘疹减少了</span><span style="color: #212121;"> 30.65%</span><span style="color: #212121;">。无不良反应报告,</span><span style="color: #212121;">96.67%</span><span style="color: #212121;">的受试者对治疗效果表示满意。</span></p> <p><img class="wscnph" src="https://img.medsci.cn/20240528/1716893973048_8439950.jpg" /><img class="wscnph" src="https://img.medsci.cn/20240528/1716894002742_8439950.jpg" /><img class="wscnph" src="https://img.medsci.cn/20240528/1716894016162_8439950.jpg" /></p> <p>综上,<span style="color: #212121;">GO </span><span style="color: #212121;">和</span><span style="color: #212121;"> RT </span><span style="color: #212121;">提取物在协同抑制炎症、改善寻常痤疮和减轻发红方面具有显著疗效。这项研究为敏感性皮肤的寻常型痤疮患者提供了一种有效且无刺激的治疗方法。</span></p> <p><span style="color: #808080; font-size: 12px;">原始出处:</span></p> <p><span style="color: #808080; font-size: 12px;">Zhang J, Liu S, Guo W, Li N. The synergistic effects of Guaiacum officinale and Rhodomyrtus tomentosa extracts in the treatment of acne vulgaris on sensitive skin. J Cosmet Dermatol. 2024 May 24. doi: 10.1111/jocd.16394. Epub ahead of print. PMID: 38790116.&nbsp;</span></p>, belongTo=, tagList=[TagDto(tagId=16414, tagName=痤疮), TagDto(tagId=491218, tagName=愈疮木)], categoryList=[CategoryDto(categoryId=28, categoryName=整形美容, tenant=100), CategoryDto(categoryId=39, categoryName=皮肤性病, tenant=100), CategoryDto(categoryId=84, categoryName=研究进展, tenant=100), CategoryDto(categoryId=20656, categoryName=梅斯医学, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, opened=1, paymentType=1, paymentAmount=0, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=1750, appHits=23, showAppHits=0, pcHits=85, showPcHits=1727, likes=0, shares=8, comments=3, approvalStatus=1, publishedTime=Tue May 28 21:12:00 CST 2024, publishedTimeString=2024-05-28, pcVisible=1, appVisible=1, editorId=6556111, editor=整形科新前沿, waterMark=0, formatted=0, deleted=0, version=4, createdBy=d3b78439950, createdName=布兜小吴, createdTime=Tue May 28 19:02:53 CST 2024, updatedBy=92910, updatedName=rayms, updatedTime=Tue May 28 21:12:48 CST 2024, ipAttribution=上海, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=J Cosmet Dermatol:愈疮木和桃金娘提取物在治疗敏感性皮肤上的寻常痤疮中展现出协同作用)], guideDownload=1, surveyId=null, surveyIdStr=null, surveyName=null)
J Cosmet Dermatol:愈疮木和桃金娘提取物在治疗敏感性皮肤上的寻常痤疮中展现出协同作用
版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2207790, encodeId=86ed220e790ae, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b4aa8440342, createdName=ms6000000013039699, createdTime=Sat Jun 01 16:52:44 CST 2024, time=2024-06-01, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2207125, encodeId=667f220e125c9, content=<a href='/topic/show?id=5718e118414' target=_blank style='color:#2F92EE;'>#痤疮#</a> <a href='/topic/show?id=d4ce114942e7' target=_blank style='color:#2F92EE;'>#愈疮木#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=114942, encryptionId=d4ce114942e7, topicName=愈疮木), TopicDto(id=71184, encryptionId=5718e118414, topicName=痤疮)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cade5395722, createdName=梅斯管理员, createdTime=Tue May 28 21:12:48 CST 2024, time=2024-05-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2207162, encodeId=1266220e1629e, content=认真学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6EF3hKja8nER8RMzxQdria9eCYFhgLTLsDOeqnvIYdeLDz5eP6EnicLuE5gibiawgno4zUA0jAR7Nbtp2llQ9fs3Mk/0, createdBy=278f1986883, createdName=医鸣惊人, createdTime=Tue May 28 21:44:54 CST 2024, time=2024-05-28, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2207172, encodeId=4000220e172a9, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Tue May 28 23:20:12 CST 2024, time=2024-05-28, status=1, ipAttribution=浙江省)]
    2024-06-01 ms6000000013039699 来自河北省

    学习了,谢谢分享

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2207790, encodeId=86ed220e790ae, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b4aa8440342, createdName=ms6000000013039699, createdTime=Sat Jun 01 16:52:44 CST 2024, time=2024-06-01, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2207125, encodeId=667f220e125c9, content=<a href='/topic/show?id=5718e118414' target=_blank style='color:#2F92EE;'>#痤疮#</a> <a href='/topic/show?id=d4ce114942e7' target=_blank style='color:#2F92EE;'>#愈疮木#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=114942, encryptionId=d4ce114942e7, topicName=愈疮木), TopicDto(id=71184, encryptionId=5718e118414, topicName=痤疮)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cade5395722, createdName=梅斯管理员, createdTime=Tue May 28 21:12:48 CST 2024, time=2024-05-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2207162, encodeId=1266220e1629e, content=认真学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6EF3hKja8nER8RMzxQdria9eCYFhgLTLsDOeqnvIYdeLDz5eP6EnicLuE5gibiawgno4zUA0jAR7Nbtp2llQ9fs3Mk/0, createdBy=278f1986883, createdName=医鸣惊人, createdTime=Tue May 28 21:44:54 CST 2024, time=2024-05-28, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2207172, encodeId=4000220e172a9, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Tue May 28 23:20:12 CST 2024, time=2024-05-28, status=1, ipAttribution=浙江省)]
    2024-05-28 梅斯管理员 来自上海
  3. [GetPortalCommentsPageByObjectIdResponse(id=2207790, encodeId=86ed220e790ae, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b4aa8440342, createdName=ms6000000013039699, createdTime=Sat Jun 01 16:52:44 CST 2024, time=2024-06-01, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2207125, encodeId=667f220e125c9, content=<a href='/topic/show?id=5718e118414' target=_blank style='color:#2F92EE;'>#痤疮#</a> <a href='/topic/show?id=d4ce114942e7' target=_blank style='color:#2F92EE;'>#愈疮木#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=114942, encryptionId=d4ce114942e7, topicName=愈疮木), TopicDto(id=71184, encryptionId=5718e118414, topicName=痤疮)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cade5395722, createdName=梅斯管理员, createdTime=Tue May 28 21:12:48 CST 2024, time=2024-05-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2207162, encodeId=1266220e1629e, content=认真学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6EF3hKja8nER8RMzxQdria9eCYFhgLTLsDOeqnvIYdeLDz5eP6EnicLuE5gibiawgno4zUA0jAR7Nbtp2llQ9fs3Mk/0, createdBy=278f1986883, createdName=医鸣惊人, createdTime=Tue May 28 21:44:54 CST 2024, time=2024-05-28, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2207172, encodeId=4000220e172a9, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Tue May 28 23:20:12 CST 2024, time=2024-05-28, status=1, ipAttribution=浙江省)]
    2024-05-28 医鸣惊人 来自山西省

    认真学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2207790, encodeId=86ed220e790ae, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b4aa8440342, createdName=ms6000000013039699, createdTime=Sat Jun 01 16:52:44 CST 2024, time=2024-06-01, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2207125, encodeId=667f220e125c9, content=<a href='/topic/show?id=5718e118414' target=_blank style='color:#2F92EE;'>#痤疮#</a> <a href='/topic/show?id=d4ce114942e7' target=_blank style='color:#2F92EE;'>#愈疮木#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=114942, encryptionId=d4ce114942e7, topicName=愈疮木), TopicDto(id=71184, encryptionId=5718e118414, topicName=痤疮)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cade5395722, createdName=梅斯管理员, createdTime=Tue May 28 21:12:48 CST 2024, time=2024-05-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2207162, encodeId=1266220e1629e, content=认真学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6EF3hKja8nER8RMzxQdria9eCYFhgLTLsDOeqnvIYdeLDz5eP6EnicLuE5gibiawgno4zUA0jAR7Nbtp2llQ9fs3Mk/0, createdBy=278f1986883, createdName=医鸣惊人, createdTime=Tue May 28 21:44:54 CST 2024, time=2024-05-28, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2207172, encodeId=4000220e172a9, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Tue May 28 23:20:12 CST 2024, time=2024-05-28, status=1, ipAttribution=浙江省)]
    2024-05-28 1209e435m98(暂无昵称) 来自浙江省

    学习了,谢谢分享

    0

相关资讯

皮肤:痤疮分级

精简汇总:痤疮四大分级皮肤科医生戳进来。

IL-17与痤疮相关性的研究进展

大量研究发现白细胞介素17(interleu-kin-17,IL-17)参与痤疮发病过程。IL-17等Th17通路相关细胞因子在早期痤疮病变中显著表达。

Nat Biotech:成功基因改造痤疮丙酸杆菌,有望用于青春痘的治疗

成功地编辑了痤疮丙酸杆菌(cutibacterium acnes)的基因组,使其分泌和产生NGAL蛋白,这种蛋白已被证明是痤疮药物异维A酸的介质,通过诱导皮脂细胞死亡来减少皮脂分泌。

J Cosmet Dermatol:一种新的乳剂治疗痤疮和改善面部毛孔的临床疗效

含有烟酰胺、兵豆果提取物和白柳树皮提取物的新型乳剂能有效改善痤疮、黑头和明显的面部毛孔。

J Cosmet Dermatol:中山大学附属第三医院团队发现:2%超分子水杨酸水凝胶与阿达帕林凝胶治疗轻中度寻常痤疮疗效相当

2% SSA和阿达帕林凝胶治疗轻中度寻常痤疮的疗效相当。2% SSA治疗轻中度寻常痤疮值得临床推广应用。

J Cosmet Dermatol:探讨皮下分离术中添加Profhilo mesogel与单纯皮下分离术治疗痤疮瘢痕的疗效:单盲、分面随机比较试验

虽然两种方法的效果无明显差异,但Profhilo更有效,具有更高的满意率和更好的生理效果。

J Cosmet Dermatol:一种可快速缓解戴口罩相关疾病的高可溶性芦丁

COVID-19大流行导致了与佩戴口罩相关的各种皮肤问题。这种高可溶性的芦丁能通过减少炎症,氧化应激和色素沉着,同时促进伤口愈合有效地解决这些问题。

J Cosmet Dermatol:595 nm脉冲染料激光联合1565 nm非剥脱点阵激光治疗红斑性痤疮瘢痕

595 nm脉冲染料激光联合1565 nm非剥脱点阵激光治疗红斑性痤疮瘢痕安全有效。

J Cosmet Dermatol:595 nm脉冲染料激光作为粉刺后红斑和粉刺的辅助干预: 一项随机、分面对照试验

脉冲染料激光可作为粉刺后红斑及粉刺的辅助治疗手段,疗效确切,患者满意度高。

J Cosmet Dermatol:痤疮丙酸杆菌、葡萄球菌皮内注射:脓疱样痤疮小鼠模型

该模型能够反映人脓疱性痤疮的临床症状和发展过程,克服了基础研究中常用的动物模型用于研究这一情况的局限性。

Baidu
map
Baidu
map
Baidu
map